An Automated Tissue Systems Pathology Test Can Standardize the Management and Improve Health Outcomes for Patients With Barrett's Esophagus

por Duits, Lucas C., Khoshiwal, Amir M., Frei, Nicola F., Pouw, Roos E., Smolko, Christian, Arora, Meenakshi, Siegel, Jennifer J., Critchley-Thorne, Rebecca J., Bergman, Jacques J.G.H.M.
Publicado 2023

The Presence of Genetic Mutations at Key Loci Predicts Progression to Esophageal Adenocarcinoma in Barrett's Esophagus

por Eluri, Swathi, Brugge, William R, Daglilar, Ebubekir S, Jackson, Sara A, Styn, Mindi A, Callenberg, Keith M, Welch, Derek C, Barr, Todd M, Duits, Lucas C, Bergman, Jacques J, Shaheen, Nicholas J
Publicado 2015

A Tissue Systems Pathology Test Outperforms the Standard-of-Care Variables in Predicting Progression in Patients With Barrett's Esophagus

por Davison, Jon M., Goldblum, John R., Duits, Lucas C., Khoshiwal, Amir M., Bergman, Jacques J., Falk, Gary W., Diehl, David L., Khara, Harshit S., Smolko, Christian, Arora, Meenakshi, Siegel, Jennifer J., Critchley-Thorne, Rebecca J., Thota, Prashanthi N.
Publicado 2023

Barrett's esophagus surveillance in a prospective Dutch multi‐center community‐based cohort of 985 patients demonstrates low risk of neoplastic progression

por Klaver, Esther, Bureo Gonzalez, Angela, Mostafavi, Nahid, Mallant‐Hent, Rosalie, Duits, Lucas C., Baak, Bert, Böhmer, Clarisse J. M., van Oijen, Arnoud H. A. M., Naber, Ton, Scholten, Pieter, Meijer, Sybren L., Bergman, Jacques J. G. H. M., Pouw, Roos E.
Publicado 2021